Definitive Contract 36C25922C0115

Award Date 8/1/22
Potential Completion Date 7/31/27
Potential Value $159K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84148, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) has awarded a $959,561.84 definitive, firm-fixed-price contract to Caredx, Inc., a for-profit medical testing company headquartered in Brisbane, California. The contract is for the provision of AlloMap and AlloSure post-heart transplant rejection surveillance tests to veterans in the Palo Alto, California area over a five-year period, with a base year and four one-year option periods. This contract award is related to a larger Indefinite Delivery...
The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
This federal contract award is for the provision of genetic blood testing services for transplant patients, specifically the AlloMap and AlloSure testing products, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California, that specializes in advanced diagnostic solutions for organ transplant patients. The contract has a ceiling value of $643,166.71 and is a Firm Fixed Price Delivery...
This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $244,800.00, is for laboratory tests and specialty transplant services. The contract is not set aside and was awarded under the VA's Veterans Integrated Service Network 9 (VISN 9) to Caredx, which has been awarded multiple indefinite...
This is a federal contract award to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $4,807,230.45, is for laboratory tests for post-transplant organ rejection and was awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 31, 2026....
This federal contract award is for the provision of TRANSPLANT TESTING KITS by Caredx, Inc., a for-profit organization that specializes in advanced medical testing products and services to support organ transplant programs. The contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), has a ceiling value of $2,397,593.00 and is structured as a Delivery Order on a Firm Fixed Price basis. The contract does not have a set-aside...

This federal contract award to Caredx, Inc., a for-profit organization headquartered in Brisbane, California, is for the provision of AlloMap gene testing services. The contract, valued at $158,760.00, was awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) and has an ultimate completion date of July 31, 2027.

Caredx, a leading provider of specialized transplant diagnostic solutions, will deliver its AlloMap gene testing services under this definitive, firm-fixed-price contract. The AlloMap test is designed to assess the risk of organ rejection in transplant recipients, supporting the VA's efforts to provide comprehensive care for its patient population. This contract is not designated as a set-aside.

In addition to this award, Caredx holds two significant Indefinite Delivery Vehicle (IDV) contracts with the VA, one for genetic blood testing services and another specifically for AlloSure kidney testing, the latter of which was awarded as a total small business set-aside. These IDVs demonstrate the VA's continued reliance on Caredx's specialized transplant diagnostic solutions across its healthcare network.

Generated 3/1/25, 9:53 AM